AKP Freiburg

AKP Freiburg (Arbeitskreis Klinische Prüfungen) is a specialized Contract Research Organization (CRO) that provides comprehensive clinical trial services to the pharmaceutical, biotechnology, and medical device sectors. Based in Freiburg, Germany, the company offers end-to-end support for Phase I-IV clinical trials, including project management, clinical monitoring, data management, and regulatory affairs. AKP is recognized for its deep expertise in the European regulatory environment and its high-quality standards in clinical data collection and biostatistics. Since its acquisition by the GBA Group in 2020, AKP has operated as a key component of GBA's Pharma division, leveraging expanded laboratory and analytical resources to serve a global client base.